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Abstract 
Ingestion of mushrooms from the genus Amanita can present detrimental consequences 
to the human body. The mushroom is frequently found in the coastal Pacific Northwest, 
Pennsylvania, New Jersey, and Ohio. Amanitin, one of the two distinct toxins isolated from 
the Amanita mushroom, is responsible for the majority of symptoms and signs seen with 
mushroom poisoning. Clinically, ingestion of these mushrooms can result in a wide range 
of clinical symptoms including nausea, vomiting, crampy abdominal pain, and diarrhea. 
There have been several case reports of patients who developed severe hepatic failure that 
required liver transplantation. Thus, it is important to recognize the symptoms early and 
treat the patients with the available agents including multidose activated charcoal, 
N-acetylcysteine, penicillin G, and Silybum. Through an extensive literature search, we found 
no published literature on amatoxin poisoning in the state of Texas. With new cases of 
amatoxin poisoning emerging in the state, it is important for healthcare providers and 
workers to have a better awareness and early recognition of the detrimental effects of 
Amanita species poisoning and to be educated to provide the proper care for this group of 
patients. 
 
Introduction 
There are over 5,000 species of mushrooms and approximately 52 species are 
poisonous to humans [1]. Amanita mushroom plays a major role in mycetismus and has 
been reported in case reports of different states in the United States. Some features that 
are used to identify Amanita species include: cream-colored gills, yellowish-brown cap, 
and solid stalk with round base [2]. Amanita species are frequently found in the coastal 
Pacific Northwest, Pennsylvania, New Jersey, and Ohio. They tend to grow in oak  
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woodlands or in lawns next to oak trees [1, 2]. This is corroborated by case reports 
dating back to the 1970s (table 1). Specifically, the majority of cases are located in the 
Northwest/Oregon and California area. There are approximately 200 species of wild 
mushrooms in the state of Texas, but no formal report of amatoxin poisoning has been 
noted in the recent literature [3]. 
Amatoxins are found within the fungal families Amanitaceae (genus Amanita), 
Agaricaceae (genus Lepiota), and Cortinariaceae (genus Galerina). Amanita species 
that contain amatoxins include: Amanita phalloides, A. virosa, A. verna, A. ocreata, 
A. bisporigera, A. suballiacea, A. tenufolia, and A. hygroscopica [4]. Among the Amanita 
species mushrooms, A. phalloides has the highest toxin content and is the most 
poisonous Amanita species. Compared to Amanita species, Galerina and Lepiota species 
mushroom have less toxin content and contribute to less detrimental health 
consequences in humans [4]. Different amatoxins are isolated and the main toxins 
isolated include alpha-, beta- and gamma-amanitins. The principal amatoxin that causes 
the majority of morbidity and mortality in the ingestion of Amanita mushroom is 
alpha-amanitin [5]. The toxin is absorbed across the intestine, and 60% of the absorbed 
toxin is excreted into the bile and undergoes enterohepatic circulation [6]. Unlike other 
poisonous mushrooms, amatoxin has a prolonged enterohepatic circulation, thus 
making it an important potential cause of acute liver failure. After the toxin returns to 
the liver and is absorbed by the hepatocytes, it inhibits RNA polymerase II and 
interrupts mRNA synthesis of vital structural proteins, leading to cellular necrosis [1]. 
Mycetismus or mushroom poisoning especially from Amanita mushrooms can be 
life-threatening. The major consequences from ingestion of these mushrooms can 
result in hepatic failure that leads to coagulopathy, encephalopathy, hepatorenal 
syndrome, and death [1]. Despite major health consequences from amatoxin mushroom 
poisoning, there is little literature that report amatoxin poisoning in the state of Texas. 
In this case report, we present a case of mycetismus from Amanita mushrooms near the 
Houston area and we also briefly discuss the pathophysiology, clinical presentation, 
and treatment options related to mushroom toxicity.  
Case Report 
A 64-year-old Chinese female presented with a 1-day history of nausea and vomiting. She 
vomited at home 10–12 times, and the vomit was clear-looking, with no blood. She also had  
6–8 episodes of watery non-bloody diarrhea. The patient had associated abdominal pain mostly in 
the lower abdomen, and it was crampy in nature associated with bowel movements. For her initial 
symptoms, she was evaluated at a local emergency room and the final working diagnosis was 
gastroenteritis. She was discharged on ciprofloxacin and loperamide. However, her symptoms failed 
to improve and she was brought to The Methodist Hospital. The patient had a past medical history of 
hypertension and took Chinese herbal medications for hypertension. On presentation, she had a 
maximum temperature of 97°F, a heart rate of 82, a blood pressure of 140/70 on sitting and 135/70 
on standing, a respiratory rate of 16, and an oxygen saturation of 97%. Her physical exam was overall 
benign. Her initial lab showed WBC 13.5, ALT 231, AST 375, PT 15.7, INR 1.3, and negative hepatitis 
serologies. She also underwent an abdominal ultrasound that was within normal limits. Upon further 
understanding of the patient’s history, it was found that she and her husband had picked up wild 
mushrooms from the sidewalk around the Houston area and cooked the mushrooms for lunch and 
dinner. The patient was admitted for elevation of liver enzymes and continued symptoms of nausea 
and vomiting. Initially, she was started on N-acetylcysteine, and the poison control center was 
contacted for further assistance in the patient’s care. With the assistance of the poison control 
personnel, they were able to identify the mushroom from the Amanita species. Since admission, the  
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patient began to have increasing levels of her liver enzymes and at one point, her ALT was 1,227 
and AST was 1,378 (fig. 1). Her prothrombin and INR levels were also elevated during the hospital 
course (fig. 2). Due to acute liver injury, she was transferred to the medical intensive care unit for 
observation and higher level of care. The husband was also admitted and had similar symptoms but 
only mild elevations in liver enzymes that only required supportive care throughout hospitalization. 
The hepatology service was consulted for the acute liver injury and penicillin G was added as part of 
the treatment. Since starting pencillin G, the patient’s liver function test continued to improve. She 
was transferred to the hospital floor on hospital day 2 and discharged the following day. 
Discussion 
Amanita poisoning occurs in three separate stages [1, 5, 7]. The first stage or 
incubation stage usually occurs from 6 to 12 h after ingestion and patients usually do 
not present any symptoms during this time. During the second stage or gastrointestinal 
stage, which takes place 6–16 h after ingestion, patients develop abdominal pain, 
nausea, vomiting, and diarrhea for up to 24 h. During the final stage or cytotoxic stage, 
between 24–48 h after ingestion of the mushroom, sign and symptoms of liver damage 
begin to develop. During this phase, patients are free of gastrointestinal symptoms, but 
they can present with jaundice and hemorrhage. There are also elevations in liver tests, 
prothrombin time, and ammonia levels. Patients can develop hepatic encephalopathy, 
profound coagulopathy, and renal failure secondary to hepatorenal syndrome. During 
the cytotoxic stage, the prolonged enterohepatic recirculation further recycles the 
amatoxin through the liver multiple times. Specifically, it is excreted into the bile duct 
and reabsorbed through the ileum and back into the portal circulation. The 
recirculation of toxin inside the body further prolongs liver damage and progresses 
from liver injury to liver failure. In severe cases, patients may require liver 
transplantation for survival.  
There are different options available for treating amatoxin poisoning. Multidose 
activated charcoal is commonly used because the toxin has a high affinity to charcoal 
and this helps to reduce the absorption of the toxin through the intestine [8]. Another 
agent that is commonly used in practice is penicillin G and works well in many settings. 
It competes with amatoxin for binding sites on serum proteins and prevents hepatocyte 
uptake [9]. Pencillin G also helps to prevent the progression of hepatic encephalopathy. 
In one study, the suggested dose for penicillin G is 40,000,000 U/day for adults and 
1,000,000 U/day for children [10]. Another beta-lactam antibiotic used in the setting of 
amatoxin poisoning is ceftazidime and it has been shown to be more effective in some 
studies than penicillin G. It is usually administered 4.5 g i.v. every 2 h [10]. Silybum 
marianum, a silymarin complex, is a flavonolignan isolated from milk thistle and 
inhibits binding of alpha-amanitin to hepatocytes [5]. It also competes with amatoxin 
for transmembrane transport. One of the major compounds isolated from silymarin is 
silybin. Silybin dihemisuccinate is usually administered at an initial dose of 5 mg/kg by 
i.v. infusion over 1 h, followed by 20 mg/kg/day by continuous i.v. infusion for 6 days 
until the liver enzymes have normalized [10]. Currently, silymarin is only incorporated 
in food supplements and is not yet approved by the FDA as a treatment for amatoxin 
poisoning. It is not available in the United States. Studies have suggested that thioctic 
acid provides a therapeutic effect on amatoxin hepatotoxicity. The chemical serves as a 
free radical scavenger and prevents lipid peroxidation of cell membrane. In the clinical 
setting, it is administered with glucose at doses of 300 mg/kg/day in four divided doses  
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and then 600 mg/kg/day and 50–150 mg/kg/day [10]. Cimetidine, a cytochrome P450 
inhibitor, is an antioxidant agent used in the treatment of amatoxin poisoning. It is 
usually given along with penicillin G at a dose of 300 mg i.v. administered every 8 h 
[10]. N-acetylcysteine (NAC, Mucomyst) supplies sulfhydryl groups to act as a substrate 
for detoxifying reactive toxic intermediates [1, 5]. Vitamin C is also used to treat this 
group of patients and it inhibits lipid peroxidation and is used as a hepatocyte protector 
[9]. Liver transplantation is reserved for patients with encephalopathy and severe liver 
decompensation.  
Despite many reported cases of amatoxin poisoning in other states of the United 
States, amatoxin poisoning has not been formally reported in Texas. According to 
Barbee et al. [3], the most common mushroom exposure in the state of Texas is 
Psilocybin, but little is known about the prevalence of Amanita exposure in the state of 
Texas. With new cases located in the state of Texas, it is increasingly important to 
recognize the deleterious effects of amatoxin poisoning and to be able to address the 
illness once the diagnosis is made. Further advances in the quality of care are necessary 
to better locate areas with growth of Amanita species and to provide adequate warning 
for travelers not to ingest the mushroom. Increasing collaboration with poison control 
centers is warranted to better diagnose and treat patients with potential amatoxin or 
other mushroom poisoning. Furthermore, with mushroom poisoning becoming more 
prevalent in the state of Texas, it is also important to educate health care providers and 
workers about early recognition of potential ingestion and medical disease 
management. 
Conclusion 
We have presented a case of Amanita poisoning in the state of Texas and with new 
cases emerging in the state of Texas, health care providers need to be have better 
awareness of the serious consequences of mycetismus from Amanita mushrooms and 
to provide a proper management plan for these patients. 
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Table 1. Literature review of reported Amanita poisoning in the last 30 years in the United States 
                   
First author  Journal, year  Clinical presentation    Region 
                   
French [9]  Clin Toxicol, 2011  3 cases of Amanita phalloides mushroom poisoning in the 
Pacific Northwest of the US 
  Oregon 
                    Cress [2]  Clin Gastroenterol Hepatol, 2011  1 case of Amanita phalloides toxicity that resulted in 
fulminant hepatic failure and required orthotopic liver 
transplantation 
  Delaware 
                    West [11]  J Med Toxicol, 2009   1 case report with delayed renal failure; renal failure 
predominant manifestation 
  Oregon/ 
Pacific Northwest 
                    Madhok [5]  Minn Med, 2007  7 Minnesota residents who developed symptoms of Amanita 
poisoning after consuming cooked mushrooms picked at a 
county park 
  Minnesota 
                    Madhok [6]  Pediatr Emerg Care, 2006  3 cases of exposure to Amanita bisporigera    Missouri 
                    Broussard [1]  Am J Gastroenterol, 2001  4 cases of Amanita virosa ingestion with clinical presentation 
from complete recovery to fulminant hepatic failure 
  Ohio 
                    Pomerance [12]  J Pediatr, 2000  a 15-year-old boy with fulminant hepatic failure after 
drinking mushroom tea (containing Amanita phalloides) 
4 days before admission 
  Florida 
                    Mullins [13]  Vet Hum Toxicol, 2000  2 cases of confirmed Amanita phalloides poisoning 
treated with hemodialysis or hemoperfusion and neither 
contributed to the clearance of amatoxin 
  Oregon 
                    Yamada [14]  West J Med, 1998  10 case reports of amatoxin poisoning in Northern California   California 
                    Warden [7]  Acad Emerg Med, 1998  4 cases of Amanita smithiana ingestion that led to acute renal 
failure 
  Oregon/ 
Pacific Northwest 
                    CDC [15]  MMWR Morb Mortal Wkly Rep, 
1997 
9 cases in Northern California required hospitalization after 
eating Amanita phalloides 
  California 
                    O’Brien [8]  Am J Gastroenterol, 1996  4 cases of Amanita mushroom poisoning    Alabama 
                    Feinfeld [16]  J Toxicol Clin Toxicol, 1994  4 cases of poisoning with amatoxin-producing mushrooms in 
suburban Long Island 
  New York 
                    Cappell [17]  J Clin Gastroenterol, 1992  3 residents developed gastrointestinal symptoms after 
ingesting Amanita phalloides type mushroom 
  New Jersey 
                    Piering [18]  Clin Chem, 1990  2 cases of Amanita virosa mushroom poisoning    Wisconsin 
                    Pinson [22]  Am J Surg, 1990  5 cases of amatoxin poisoning, 4 of whom underwent liver 
transplantation 
  Oregon 
                    Woodle [19]  JAMA, 1985  orthotopic liver transplantation in a 3-year-old girl with 
acute hepatic failure secondary to Amanita poisoning 
  California 
                    Olson [20]  West J Med, 1982  10 cases of Amanita phalloides poisoning    California  
(San Francisco) 
                    Becker [21]  West J Med, 1976  15 cases of Amanita phalloides poisoning between 1964 and 
1974 
  California 
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Fig. 1. Elevation of liver enzymes since admission to hospital indicating severe liver injury. 
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Fig. 2. Elevation of prothrombin time (a) and INR (b) indicating worsening of liver synthetic function 
throughout the hospital course. 
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